Master Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies as Assessed by Biomarker Status and Cognition
Hoffmann-La Roche
Summary
This study is a pre-screening process used to assess participants' potential eligibility for Roche interventional Alzheimer's disease studies.
Eligibility
- Age range
- 50–90 years
- Sex
- All
- Healthy volunteers
- No
Inclusion Criteria: \- Report of objective or subjective memory concerns (by the participant and/or their informant) within the last year with or without a previous clinical diagnosis of MCI or dementia due to AD. Exclusion Criteria: * Dependency in basic activities of daily living (bADLs) due to cognitive impairment * Visual or auditory impairment that would prevent them from performing the cognitive assessments (eyeglasses and hearing aids are permitted) * Any self-reported evidence or known diagnosis of a neurological or neurodegenerative condition that may lead to cognitive impairment o…
Interventions
- OtherNo Intervention
Participants will have their blood drawn and cognitive score measured by the ISLT.
Locations (211)
- University of Alabama at BirminghamBirmingham, Alabama
- Banner Alzheimer?s InstitutePhoenix, Arizona
- Banner Sun Health Research InstituteSun City, Arizona
- Sun Valley Research Center, Inc.Imperial, California
- Inglewood ClinicalsInglewood, California
- Irvine Center for Clinical ResearchIrvine, California